Newsletter | July 30, 2025

07.30.25 -- Ten To-Do's For Transitioning From Academia To Entrepreneurship

SPONSOR

Expertise Where It Matters

Entrust that your program is in hands you can rely on, where integrity is paramount, and excellence is the standard.

FEATURED ARTICLE

Ten To-Do's For Transitioning From Academia To Entrepreneurship

Cuts to federal research funding at universities and research organizations are pushing academic scientists into life sciences entrepreneurship. Experts at Sidley offer tips for the transition.

INDUSTRY INSIGHTS

Implementing An ERP System: 5 Key Steps To A Successful Rollout

Explore best practices for embarking on ERP implementation. These insights can help ensure that your investment in the right solution pays off, setting the stage for long-term success.

Focus On Your Core Business Strategy

Eurofins PSS helped a Southeast U.S. manufacturer outsource lab functions by transitioning key staff, reducing costs, and fully managing a compliant GMP QC lab program.

How FAIR Data Principles Deliver Clinical Success

Prioritize data management that adheres to FAIR principles — findable, accessible, interoperable, and reusable — to gain operational insights that enable quick decisions and ensure participant well-being.

The Streetlight Effect

Examine the shortcomings of existing clinical trial finders, particularly regarding the accessibility of eligibility criteria for patients seeking treatment options.

Using Data To Revolutionize Intensified Cell Line Development

Discover how N-1 perfusion and concentrated fed-batch can revolutionize biomanufacturing by exploring an advanced data analytics tool that simplifies early-stage upstream process optimization.

Optimizing Clinical Data: Reducing Redundancy For Efficiency

Enabling sites to focus solely on critical data facilitates faster data entry, reduces queries, and fosters better relationships between sponsors, CROs, and sites.

BsAb Development With Structural Innovation, Enhanced Manufacturability

Bispecific antibodies (bsAbs) offer transformative therapeutic potential through dual-target engagement, but their complex structure presents significant manufacturing challenges.